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Background: Retaining participants in cohort studies with multiple follow-up waves is difficult. Commonly,
researchers are faced with the problem of missing data, which may introduce biased results as well as a loss of
statistical power and precision. The STROBE guidelines von Elm et al. (Lancet, 370:1453-1457, 2007); Vandenbroucke
et al. (PLoS Med, 4:e297, 2007) and the guidelines proposed by Sterne et al. (BMJ, 338:b2393, 2009) recommend
that cohort studies report on the amount of missing data, the reasons for non-participation and non-response, and
the method used to handle missing data in the analyses. We have conducted a review of publications from cohort
studies in order to document the reporting of missing data for exposure measures and to describe the statistical
methods used to account for the missing data.
Methods: A systematic search of English language papers published from January 2000 to December 2009 was
carried out in PubMed. Prospective cohort studies with a sample size greater than 1,000 that analysed data using
repeated measures of exposure were included.
Results: Among the 82 papers meeting the inclusion criteria, only 35 (43%) reported the amount of missing data
according to the suggested guidelines. Sixty-eight papers (83%) described how they dealt with missing data in the
analysis. Most of the papers excluded participants with missing data and performed a complete-case analysis
(n = 54, 66%). Other papers used more sophisticated methods including multiple imputation (n = 5) or fully Bayesian
modeling (n = 1). Methods known to produce biased results were also used, for example, Last Observation Carried
Forward (n = 7), the missing indicator method (n = 1), and mean value substitution (n = 3). For the remaining 14
papers, the method used to handle missing data in the analysis was not stated.
Conclusions: This review highlights the inconsistent reporting of missing data in cohort studies and the continuing
use of inappropriate methods to handle missing data in the analysis. Epidemiological journals should invoke the
STROBE guidelines as a framework for authors so that the amount of missing data and how this was accounted for
in the analysis is transparent in the reporting of cohort studies.
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reproduction in any medium, provided the orresearchers with the opportunity to obtain information
regarding changes in the participants’ exposure and out-
come measures. Incorporating the repeated measures of
the exposure in the epidemiological analysis is especially
important if the current exposure (or change in exposure)
is thought to be more predictive of the outcome than the
participants’ baseline measurement [1] or the researcher is
interested in assessing the effect of a cumulative exposure
[2]. The time frames for these follow-up waves of data col-
lection can vary from one to two years up to 20 to 30 yearsral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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posure and outcome measures over time can lead to miss-
ing data for reasons such as participants not being
traceable, too sick to participate, withdrawing from the
study, refusing to respond to certain questions or death
[3,4]. In this paper we focus on missing data in exposure
measures that are made repeatedly in a cohort study be-
cause studies of this type (in which the outcome is often a
single episode of disease or death obtained from a registry
and therefore, known for all participants) are common and
increasingly important in chronic disease epidemiology.
Further research is needed on the consequences of and best
methods for handling missing data in such study designs,
but simulation and case studies have shown that missing
covariate data can lead to biased results and there may be
gains in precision of estimation of effects if multiple imput-
ation is used to handle missing covariate data [5-7].
If participants with missing data and complete data
differ with respect to exposure and outcome, estimates
of association based on fully observed cases (known as a
complete-case analysis) might be biased. Further, the
estimates from these analyses will have less precision
than an analysis of all participants in the absence of
missing data. As well as complete-case analysis, there
are other methods available for dealing with missing data
in the statistical analysis [8,9]. These include ad hoc
methods such as Last Observation Carried Forward and
the missing indicator method, and more advanced
approaches such as multiple imputation and likelihood-
based formulations.
The STROBE guidelines for reporting of observational
studies, published in 2007, state that the method for hand-
ling missing data should be addressed and furthermore,
that the number of individuals used for analysis at each
stage of the study should be reported accompanied by rea-
sons for non-participation or non-response [10,11]. The
guidelines published by Sterne et al. [12], an extension to
the STROBE guidelines, provide general recommenda-
tions for the reporting of missing data in any study
affected by missing data and specific recommendations for
reporting the details of multiple imputation.
In this paper we: 1) give a brief review of the statistical
methods that have been proposed for handling missing
data and when they may be appropriate; 2) review how
missing exposure data has been reported in large cohort
studies with one or more waves of follow-up, where the
repeated waves of exposures were incorporated in the
statistical analyses; and 3) report how the same studies
dealt with missing data in the statistical analyses.
Methods
Statistical methods for handling missing data
Complete-case analysis only includes in the analysis parti-
cipants with complete data on all waves of data collection,thereby potentially reducing the precision of the estimates
of the exposure-outcome associations [2]. The advantage
of using complete-case analysis is that it is easily imple-
mented, with most software packages using this method
as the default. The estimates of the associations of interest
may be biased if the participants with missing data are not
similar to those with complete data. To be valid,
complete-case analyses must assume that participants with
missing data can be thought of as a random sample of
those that were intended to be observed (commonly re-
ferred to in the missing data nomenclature as missing
completely at random (MCAR) [13]), or at least that the
likelihood of exposure being missing is independent of the
outcome given the exposures [5].
There are three commonly used ad hoc approaches for
handling missing data, all of which can lead to bias
[3,12,14]. The Last Observation Carried Forward (LOCF)
method replaces the missing value in a wave of data col-
lection with the non-missing value from the previous
completed wave for the same individual. The assumption
behind this approach is that the exposure status of the
individual has not changed over time. The mean value
substitution method replaces the missing value with the
average value calculated over all the values available
from the other waves of data collection for the same in-
dividual. Both LOCF and mean value substitution falsely
increase the stated precision of the estimates by failing
to account for the uncertainty due to the missing data
and generally give biased results, even when the data are
MCAR [7,15]. The Missing Indicator Method is applied
to categorical exposures and includes an extra category
of the exposure variable for those individuals with miss-
ing data. Indicator variables are created for the analysis,
including an indicator for the missing data category [16].
This method is simple to implement, but also produces
biased results in many settings, even when the data are
MCAR [6,12].
Multiple Imputation (MI) begins by imputing values
for the missing data multiple times by sampling from an
imputation model (using either chained equations
[17,18] or a multivariate normal model [19]). The imput-
ation model should contain the variables that are to be
included in the statistical model used for the epidemio-
logical analysis, as well as auxiliary variables that may
contain information about the missing data, and a
“proper” imputation procedure incorporates appropriate
variability in the imputed values. The imputation process
creates multiple ‘completed’ versions of the datasets.
These ‘completed datasets’ are analysed using the appro-
priate statistical model for the epidemiological analysis
and the estimates obtained from each dataset are aver-
aged to produce one overall MI estimate. The standard
error for this overall MI estimate is derived using
Rubin’s rules, which account for variability between-and
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lyses of the ‘completed datasets’ [3,13]. By accounting
for the variability between the completed (imputed)
datasets, MI produces a valid estimate of the precision
of the final MI estimate. When the imputation is per-
formed using standard methods that are now available
in many packages, with appropriate model specifications
to reflect the structure of the data, the resulting MI esti-
mate will be valid (unbiased parameter estimates with
nominal confidence interval coverage) if the missing
data are ‘Missing At Random’ (MAR) [5]. MAR
describes a situation where the probability of being
missing for a particular variable (e.g. waist circumfer-
ence) can be explained by other observed variables in
the dataset, but is (conditionally) independent of the
variable itself (that is, waist circumference) [13]. On the
other hand, MI may produce biased estimates if the data
are ‘Missing Not At Random’ (MNAR), which occurs
when the study participants with missing data differ
from the study participants with complete data in a
manner that cannot be explained by the observed data
in the study [13].
MI is now implemented in many major statistical
packages (including Stata [20] and SAS [21]) making it
an easily accessible method. However, it can be a time-
intensive process to impute multiple datasets, analyse
the ‘completed datasets’ and combine the results; and
the imputation model can be complex since it must con-
tain the exposure and outcome variables included in the
analysis model, auxiliary variables and any interactions
that will be included in the final analysis model [22,23].
Sterne et al. [12] have described a number of pitfalls that
can be encountered in the imputation procedure that
might lead to biased results for the epidemiological ana-
lysis of interest.
Missing data can also be handled with the following
more sophisticated methods: maximum likelihood-based
formulations, fully Bayesian models and weighting meth-
ods. Likelihood-based methods use all of the available in-
formation (i.e. information from participants with both
complete and incomplete data) to simultaneously estimate
both the missing data model and the data analysis model,
eliminating the need to handle the missing data directly
[3,8,24,25], although in many cases the MAR assumption
is also invoked to enable the missing data model to be
ignored. Bayesian models also rely on a fully specified
model that incorporates both the missingness process and
the associations of interest [12,15,26]. Weighting methods
apply weights that correspond to the inverse probability of
a data observation being observed, to the observed data to
account for the missing data [22,25]. These methods may
improve the precision of the estimates compared with
complete-case analysis. However, they are also dependent
on assumptions about the missingness mechanism and insome cases on specifying the correct missingness model.
In general, these methods require tailored programming
which can be time consuming and requires specialist ex-
pertise [15].
Criteria for considering studies in this review
For this review we selected prospective cohort studies
that analysed exposure data collected after initial recruit-
ment during the follow-up period (i.e. studies looking at
a change in exposure or at a time varying covariate). We
restricted our review to cohort studies with more than
1,000 participants, as we thought it was more likely for
there to be more missing data in follow-up measure-
ments of exposures in large cohort studies (typically
population based studies) compared to small cohorts
(often based on a specific clinical population). For co-
hort studies reported in multiple papers, we included
only the most recent original research article. Studies
that only used data collected at baseline or at one of the
follow-up waves in the analysis, and studies that newly
recruited participants at one of the waves after baseline
were excluded. We did not place any restrictions on the
types of exposures or outcomes studied or the type of
statistical analysis performed.
Search strategy
PubMed was searched for English language papers pub-
lished between January 2000 and December 2009. We
chose January 2000 as a starting date because the first
widely available statistical software package for imple-
menting MI, the NORM package [27], was developed in
1997 and updated in 1999. Search terms included: “Co-
hort Studies”[MeSh] AND (“attrition” OR “drop out” OR
“longitudinal change” OR “missing data” OR “multiple
exposure” OR “multiple follow-up” OR “multiple waves”
OR “repeated exposure” OR “repeated follow-up” OR
“repeated waves” OR “repeated measures” OR “time
dependent covariates” OR “time dependent” OR “time
varying covariate” OR “cumulative average”).
We carried out a further search of cohort studies listed
in the web appendix of the paper by Lewington et al.
[28], to ensure that any known large cohort studies were
not missed in the original PubMed search. These cohort
studies were established in the 1970s and 1980s, allow-
ing them time to measure repeated waves of exposure
on their participants and to publish these results during
our study period (i.e. between 2000 and 2009).
Methods of the review
AK reviewed all articles; any uncertainties regarding the
statistical method used to handle the missing data were
resolved by discussion with JAS, and AK extracted the
data. Additional tables and methods sections from jour-
nal websites were checked if referred to in the article.
Table 1 Summary of cohort studies included in the
review












Number of participants recruited at baseline






20,000 + 9 (11)
Date of baseline recruitment (decade recruitment started)
Not stated in paper 5 (6)





Number of follow-up waves used in the analysis
Number not stated 12 (15)






Statistical methods for epidemiological analysis†
Cox proportional hazards regression^ 37{
Time-varying covariates 35
Time-invariant covariates 3







Table 1 Summary of cohort studies included in the
review (Continued)
Logistic regression 3
Standard linear regression 3
Standard logistic regression 9
Other methods 6
† The total number of papers is 83 because one paper used two analysis
models: a Cox proportional hazards model for a time to event outcome and a
linear mixed effects model for a numerical outcome.
^ Note one paper used a parametric survival model.
{ One paper incorporated their repeated measures of exposures using both a
time varying covariate and time-invariant covariates.
*One paper had a numerical and binary outcome.
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and the methods used to handle the missing data
according to the recommendations given by the
STROBE guidelines [10,11] and Sterne et al. [12]. The
information extracted is summarised in Tables 1 and 2
and Additional file 1: Table S1.
Results
Study selection
We identified 4,277 articles via the keyword search. A
total of 3,684 articles were excluded based on their title
and abstract, leaving 543 articles for further evaluation.
Of these, 471 articles were excluded and 72 articles were
found to be appropriate for the review. A further ten
studies were identified from the reference list of Lewing-
ton et al. [28] (Figure 1), giving 82 studies included in
this review. The reasons for excluding studies are out-
lined in Figure 1, the most common reasons were sam-
ple size of less than 1,000 participants (54%), study
design was not a prospective cohort (19%), and did not
report original research findings (13%).
Characteristics of included studies
The characteristics of the 82 studies included are sum-
marised in Table 1 and further details can be found in the
additional table (see Additional file 1: Table S1). The stud-
ies included ranged from smaller studies that recruited
1,000 to 2,000 participants at baseline to larger studies
with more than 20,000 participants, and the number pub-
lished annually increased steadily from two papers in 2000
to 16 papers in 2009. The majority of studies recruited
their participants in the decades 1980 to 1989 (n= 25),
and 1990 to 1999 (n= 30). Cox proportional hazards re-
gression was the most common statistical method used
for the epidemiological analysis (n= 37) to analyse the
repeated measures of exposure, with 35 of these papers in-
corporating the repeated exposure(s) as a time varying
covariate and the remaining two papers including a single
measure of the covariate derived from repeated assess-
ments. Generalised Estimating Equations with a logistic
(n= 10) or linear regression (n= 3) and generalised linear
Table 2 Missing data features reported by the studies
Features reported Number of
papers (N= 82) (%)
Was the amount of missing data reported?
Yes 66 (80%)
Missing data reported for each follow-up
wave used in the analysis
35
A general statement was made about
the amount of missing data or the amount
of completed follow-up (how many
participants attended at least one wave or
only the final follow-up wave)
22
Indicated number that completed all waves
of follow-up (i.e. number included in
final sample)
6




Assessed differences between individuals with complete data and
those with incomplete data?
Yes 26 (32%)
Provided a table comparing distributions of
key exposures and outcome variables for those
with missing and non-missing information
6
Table not provided but some summary
statistics included in text
4
General comment provided (did not include




Reasons were given for the missing data 13 (16%)
Statistical method for handling missing data†
Method not stated 14 (16%)
Complete-case analysis assumed 9 (11%)
Complete-case analysis 54 (66%)
Weighted 1
Unweighted 53
Exclude participants with missing data at
any repeated waves of exposure
38
Exclude participant data record for waves of
data collection with missing exposure data††
15
Missing Indicator Method 1 (1%)
Mean value substitution 3 (4%)
Last Observation Carried Forward 7 (9%)
Multiple Imputation 5 (6%)
Details provided for the multiple imputation:
Indicated how many imputations
were performed
4
Indicated which variables were included in
the imputation model
2
Compared results from multiple imputation
with complete case analysis
3
Performed a sensitivity analysis under
different assumptions for missing data
4
Table 2 Missing data features reported by the studies
(Continued)
Fully Bayesian Model 1 (1%)
† Three papers used more than one method to handle their missing exposure
data.
†† These studies assessed both exposure and outcome measures repeatedly
over the waves of data collection. The data were analysed using either
Generalised Estimating Equations (GEEs) or mixed-effects models to account
for the correlated outcome data within an individual and excluded participant
data records for waves where the exposure data were missing.
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regression (n= 13)) were the next most common epi-
demiological analyses used.Missing covariate data at follow-up
The methods used by the selected papers for handling
missing data are summarised in Table 2. Sixty-six papers
(80%) commented on the amount of missing data at follow-
up. Of these, only 35 papers provided information about
the proportion of participants lost to follow-up at each
wave. The remaining 31 papers provided incomplete details
about the amount of missing data at each wave: 22 papers
made a general comment about the amount of missing
data; six papers reported the amount of missing data for the
final wave but gave no detail regarding the number of parti-
cipants available at previous waves of data collection (in-
cluding baseline); and three papers only reported the
amount of missing data for a few of the variables.
Of the 29 papers published after 2007, nine papers did
not state the proportion of missing data at each follow
up wave, three papers provided a comment as to why
the data were missing and eight papers compared the
baseline covariates for those with and without missing
covariate data at the repeated waves of follow up.
Among those papers that provided information on
missing data, the proportion of covariate data missing at
any follow-up wave ranged from 2% to 65%. Twenty-six
papers (32%) compared the key variables of interest for
those who did and did not have data from post-baseline
waves, but only six of these presented the results in de-
tail while the rest commented briefly in the text on
whether or not there was a difference.Methods used to deal with missing data at follow-up
The most common methods used to deal with missing
data were complete-case analysis (n = 54), LOCF (n = 7)
and MI (n = 5). Of the 54 papers that used complete-
case analysis: 38 excluded participants who were missing
exposure data at any of the waves of data collection from
the analysis; one paper also excluded participants with
any missing exposure data but used a weighted analysis
to deal with the missing data; and the remaining 15
papers, where both the exposure and outcome measures
were assessed repeatedly at each wave of data collection,
Potentially relevant 
articles 
n = 543 
Articles excluded based on 
titles and abstracts 
n = 3,684 
Articles that did not meet 
inclusion criteria 
N = 471 
Studies included in the 
review 
n = 82 
Papers retrieved from search 
of known cohort studies 
n = 10 
Papers that met inclusion 
criteria  
n = 72 
Number of hits  
n = 4,227 
PubMed Search 
conducted in 2010 
Reasons articles were excluded 
n = 4,155 
2,236 had less than 1,000 participants 
372 used only one wave of data in the analysis 
103 used data from a study already included in the review 
547 did not report original research findings 
100 were descriptive papers 
356 were methods papers 
5 were evaluation papers 
86 were review papers 
807 did not use a prospective cohort design 
47 added new participants to follow up waves of the 
original study participants 
17 the unit of analysis was not the individual 
26 retrieved data from databases  
Figure 1 Search results.
Karahalios et al. BMC Medical Research Methodology 2012, 12:96 Page 6 of 10
http://www.biomedcentral.com/1471-2288/12/96excluded participant data records for waves where the
exposure data were missing. Fourteen papers did not
state the method used to deal with the missing data, al-
though nine of these papers performed a Cox regression
model using SAS [21] or Stata [20] and we therefore
assumed that they used a complete-case analysis
(Table 2). Both papers published in 2000 used complete-
case analysis. From 2001 to 2009, the proportion of
papers using complete-case analysis ranged from 25% to
65%. Methods known to produce biased results (i.e.
LOCF, the missing indicator method and mean value
substitution) continue to be used, with four papers using
these methods in 2009.
Of the five papers that used MI [29-33], two papers
[29,30] compared the characteristics of the participants
with and without missing data. For the MI, three of the
five papers [30,31,33] provided details of the imputation
process including the number of imputations performed
and the variables included in the imputation model, and
compared the results from the MI analysis to results
from complete-case analysis. The other two papers
[29,32] provided details about the number of imputa-
tions performed but did not describe the variables
included in their imputation model and did not compare
the MI results to the complete-case analysis.
Discussion
We identified 82 cohort studies of 1,000 or more partici-
pants that were published from 2000 to 2009 and whichanalysed exposure data collected from repeated follow-
up waves. The reporting of missing data in these studies
was found to be inconsistent and generally did not fol-
low the recommendations set out by the STROBE guide-
lines [10,11] or the guidelines set out by Sterne et al.
[12]. The STROBE guidelines recommend that authors
report the number of participants who take part in each
wave of the study and give reasons why participants did
not attend a wave. Only three papers [30,34,35] followed
the STROBE guidelines fully. The majority of papers did
not provide a reason or comment for why study partici-
pants did not attend each wave of follow-up. Sterne
et al. [12] recommend that the reasons for missing data
be described with respect to other variables and that
authors investigate potentially important differences be-
tween participants and non-participants.
The STROBE guidelines were published in 2007. Of
the nine papers published after 2007, only one followed
the STROBE guidelines fully. This suggests that either
journal editors are not using these guidelines or authors
are not considering the impact of missing covariate data
in their research.
A review of missing data in cancer prognostic studies
published in 2004 by Burton et al. [36] and a review of
developmental psychology studies published in 2009 by
Jelicic et al. [3] reported similar findings to ours. Burton
et al. [36] found a deficiency in the reporting of missing
covariate data in cancer prognostic studies. After review-
ing 100 articles, they found that only 40% of articles
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missing covariate data and only 12 articles would have
satisfied their proposed guidelines for the reporting of
missing data. We observed in our review, of articles pub-
lished from 2000 to 2009, that a larger proportion of
articles reported the method used to handle the missing
data in the analysis but that many articles were still not
reporting the amount of missing data and the reasons
for missingness.
The cohort studies we identified used numerous meth-
ods to handle missing data in the exposure-outcome
analyses. Although some studies used advanced statis-
tical modelling procedures (e.g. MI and Bayesian), the
majority removed individuals with missing data and per-
formed a complete-case analysis; a method that may
produce biased results if the missing data are not
MCAR. Jelicic et al. also found in their review that a
large proportion of studies used complete-case analysis
to handle their missing data [3]. For studies with a large
proportion of missing data, excluding participants with
missing data may also reduce the precision of the ana-
lysis substantially. Ad hoc methods (e.g. LOCF, the miss-
ing indicator method and mean value substitution),
which are generally not recommended [16,25] because
they fail to account for the uncertainty in the data and
may produce biased estimates [12], continue to be used.
Although MI is becoming more accessible, only five
studies used this method. The reporting of the imput-
ation procedure was inconsistent and often incomplete.
This was also observed by two independent reviews of
the reporting of MI in the medical journals: BMJ, JAMA,
Lancet and the New England Journal of Medicine
[12,37]. Future studies should follow the recommenda-
tions outlined by Sterne et al. [12] to ensure that enough
details are provided about the MI procedure, especially
the implementation and details of the imputation model-
ling process.
Strengths and limitations of the literature review
We aimed to complete a comprehensive review of all
papers published that analysed exposure variables mea-
sured at multiple follow-up waves. Several keywords
were used in order to obtain as many articles as possible.
The keyword search was then supplemented with cohort
studies identified from a pooled analysis of 61 cohort
studies. Although a large number of abstracts and stud-
ies were identified, some cohort studies might have been
missed. If multiple papers were identified from one
study, the most recent article was included in the review,
which might have led us to omit papers from the same
study that used a more appropriate missing data
method. Our search criteria only included papers written
in English and only PubMed was searched. Our search
strategy was limited to articles published between 2000and 2009. On average three papers of the type we fo-
cussed on were published each year from 2000 to 2002
and the number has increased since then, so it seems
unlikely that many papers were published before this
time. Also, MI was not as accessible prior to 1997, so
papers published before 2000 were more likely to have
used complete case analysis or other ad hoc methods.
Conclusions
With the increase in the number of cohort studies analys-
ing data with multiple follow-up waves it is essential that
authors follow the STROBE guidelines [10,11] in conjunc-
tion with the guidelines proposed by Sterne et al. [12] to
report on the amount of missing data in the study and the
methods used to handle the missing data in the analyses.
This will ensure that missing data are reported with
enough detail to allow readers to assess the validity of the
results. Incomplete data and the statistical methods used
to deal with the missing data can lead to bias, or be ineffi-
cient, and so authors should be encouraged to use online
supplements (if necessary) as a way of publishing both the
details of the missing data in their study and the details of
the methods used to deal with the missing data.
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